Medical Countermeasures Lassa Fever Vaccine Study Supports Advancement to Phase I TrialAugust 14, 2024
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024
Case Report: First Lab-Confirmed H5N2 Case in Mexico Infectious Diseases August 19, 2024 In April 2024, laboratory results from a hospitalized patient in Mexico City showed the first direct evidence of human infection caused…
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health EmergenciesAugust 27, 2024
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for MarburgApril 3, 2024
State Department Seeks Contract Support for Office of Weapons of Mass Destruction TerrorismFebruary 19, 2024
Infectious Diseases New Viral Target Could Help Combat Global Measles ResurgenceGlobal Biodefense StaffJuly 1, 2024
Pandemic Accord Negotiations Fall Short, Outcomes to Be Shared at World Health Assembly Health Security May 24, 2024
New Strategic Framework for Mpox Outbreak Control and Medical Countermeasures Infectious Diseases May 24, 2024
Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024
New Unusual Giant Virus Discovered in Wastewater Treatment Plant Near Vienna Pathogens April 24, 2024
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for Marburg
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health EmergenciesAugust 27, 2024
IFPMA Statement on the 9th Meeting of the Intergovernmental Negotiating Body for a Pandemic AgreementMarch 21, 2024
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for MarburgApril 3, 2024
